Voyager Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Voyager Therapeutics, Inc. (VYGR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 1.98 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-06
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 470.73K shares, a 255.98% increase year-over-year.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 320.21K shares, a 9.49% increase year-over-year.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-06-30 was -149.63K shares, a 155.46% decline year-over-year.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-03-31 was 756.06K shares, a 227.33% increase year-over-year.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 1.40M shares, a 50.99% increase from fiscal 2024.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 925.48K shares, a 29.39% increase from fiscal 2023.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 715.27K shares, a 70.27% decline from fiscal 2022.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 2.41M shares, a 21.11% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 1.98M shares 10-Q · filed 2026-08-06 | ||||
| 2025-12-31 | 470.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 790.94K shares derived: sum of 2 quarters · filed 2026-03-09 | 641.31K shares derived: sum of 3 quarters · filed 2026-03-09 | 1.40M shares 10-K · filed 2026-03-09 | |
| 2025-09-30 | 320.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 170.58K shares derived: sum of 2 quarters · filed 2025-11-10 | 926.64K shares 10-Q · filed 2025-11-10 | 1.06M shares derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-06-30 | -149.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 606.42K shares 10-Q · filed 2025-08-06 | 738.65K shares derived: sum of 3 quarters · filed 2026-05-07 | 1.03M shares derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-03-31 | 756.06K shares 10-Q · filed 2026-05-07 | 162.44K shares 10-Q · filed 2025-05-06 | 888.29K shares derived: sum of 2 quarters · filed 2026-05-07 | 1.18M shares derived: sum of 3 quarters · filed 2026-05-07 | 1.45M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 132.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 424.68K shares derived: sum of 2 quarters · filed 2025-03-11 | 694.50K shares derived: sum of 3 quarters · filed 2025-03-11 | 925.48K shares 10-K · filed 2025-03-11 | |
| 2024-09-30 | 292.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 562.27K shares derived: sum of 2 quarters · filed 2024-11-12 | 793.24K shares 10-Q · filed 2024-11-12 | 1.18M shares derived: sum of 4 quarters · filed 2024-11-12 | |
| 2024-06-30 | 269.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 500.79K shares 10-Q · filed 2024-08-06 | 889.28K shares derived: sum of 3 quarters · filed 2024-08-06 | 938.41K shares derived: sum of 4 quarters · filed 2024-08-06 | |
| 2024-03-31 | 230.97K shares 10-Q · filed 2024-05-13 | 619.46K shares derived: sum of 2 quarters · filed 2024-05-13 | 668.59K shares derived: sum of 3 quarters · filed 2024-05-13 | 801.21K shares derived: sum of 4 quarters · filed 2024-05-13 | |
| 2023-12-31 | 388.49K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 437.61K shares derived: sum of 2 quarters · filed 2024-02-28 | 570.24K shares derived: sum of 3 quarters · filed 2024-02-28 | 715.27K shares 10-K · filed 2024-02-28 | |
| 2023-09-30 | 49.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 181.75K shares derived: sum of 2 quarters · filed 2023-11-06 | 326.79K shares 10-Q · filed 2023-11-06 | 373.51K shares derived: sum of 4 quarters · filed 2023-11-06 | |
| 2023-06-30 | 132.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 277.66K shares 10-Q · filed 2023-08-03 | 324.38K shares derived: sum of 3 quarters · filed 2023-08-03 | 1.41M shares derived: sum of 4 quarters · filed 2023-08-03 | |
| 2023-03-31 | 145.03K shares 10-Q · filed 2023-05-09 | 191.76K shares derived: sum of 2 quarters · filed 2023-05-09 | 1.28M shares derived: sum of 3 quarters · filed 2023-05-09 | 1.61M shares derived: sum of 4 quarters · filed 2023-05-09 | |
| 2022-12-31 | 46.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 1.13M shares derived: sum of 2 quarters · filed 2023-03-07 | 1.46M shares derived: sum of 3 quarters · filed 2023-03-07 | 2.41M shares 10-K · filed 2023-03-07 | |
| 2022-09-30 | 1.08M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 1.42M shares derived: sum of 2 quarters · filed 2022-11-08 | 2.36M shares 10-Q · filed 2022-11-08 | 2.86M shares derived: sum of 4 quarters · filed 2022-11-08 | |
| 2022-06-30 | 332.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 1.27M shares 10-Q · filed 2022-08-04 | 1.77M shares derived: sum of 3 quarters · filed 2022-08-04 | 2.31M shares derived: sum of 4 quarters · filed 2022-08-04 | |
| 2022-03-31 | 942.10K shares 10-Q · filed 2022-05-04 | 1.44M shares derived: sum of 2 quarters · filed 2022-05-04 | 1.98M shares derived: sum of 3 quarters · filed 2022-05-04 | 2.67M shares derived: sum of 4 quarters · filed 2022-05-04 | |
| 2021-12-31 | 499.18K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 1.04M shares derived: sum of 2 quarters · filed 2022-03-08 | 1.73M shares derived: sum of 3 quarters · filed 2022-03-08 | 1.99M shares 10-K · filed 2022-03-08 | |
| 2021-09-30 | 538.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 1.23M shares derived: sum of 2 quarters · filed 2021-11-02 | 1.49M shares 10-Q · filed 2021-11-02 | 1.81M shares derived: sum of 4 quarters · filed 2021-11-02 | |
| 2021-06-30 | 687.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 948.57K shares 10-Q · filed 2021-08-09 | 1.28M shares derived: sum of 3 quarters · filed 2021-08-09 | 1.71M shares derived: sum of 4 quarters · filed 2021-08-09 | |
| 2021-03-31 | 261.11K shares 10-Q · filed 2021-05-10 | 588.16K shares derived: sum of 2 quarters · filed 2021-05-10 | 1.02M shares derived: sum of 3 quarters · filed 2021-05-10 | 1.28M shares derived: sum of 4 quarters · filed 2021-05-10 | |
| 2020-12-31 | 327.05K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 756.53K shares derived: sum of 2 quarters · filed 2021-02-25 | 1.02M shares derived: sum of 3 quarters · filed 2021-02-25 | 1.16M shares 10-K · filed 2021-02-25 | |
| 2020-09-30 | 429.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 689.12K shares derived: sum of 2 quarters · filed 2020-11-09 | 837.34K shares 10-Q · filed 2020-11-09 | 909.99K shares derived: sum of 4 quarters · filed 2020-11-09 | |
| 2020-06-30 | 259.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 407.85K shares 10-Q · filed 2020-08-10 | 480.50K shares derived: sum of 3 quarters · filed 2020-08-10 | 561.57K shares derived: sum of 4 quarters · filed 2020-08-10 | |
| 2020-03-31 | 148.22K shares 10-Q · filed 2020-05-06 | 220.87K shares derived: sum of 2 quarters · filed 2020-05-06 | 301.94K shares derived: sum of 3 quarters · filed 2020-05-06 | 405.61K shares derived: sum of 4 quarters · filed 2020-05-06 | |
| 2019-12-31 | 72.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | 153.71K shares derived: sum of 2 quarters · filed 2020-03-03 | 257.39K shares derived: sum of 3 quarters · filed 2020-03-03 | 361.43K shares 10-K · filed 2020-03-03 | |
| 2019-09-30 | 81.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 184.75K shares derived: sum of 2 quarters · filed 2019-11-06 | 288.78K shares 10-Q · filed 2019-11-06 | 391.73K shares derived: sum of 4 quarters · filed 2019-11-06 | |
| 2019-06-30 | 103.68K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 207.72K shares 10-Q · filed 2019-08-09 | 310.66K shares derived: sum of 3 quarters · filed 2019-08-09 | 536.05K shares derived: sum of 4 quarters · filed 2019-08-09 | |
| 2019-03-31 | 104.04K shares 10-Q · filed 2019-05-07 | 206.99K shares derived: sum of 2 quarters · filed 2019-05-07 | 432.38K shares derived: sum of 3 quarters · filed 2019-05-07 | 725.77K shares derived: sum of 4 quarters · filed 2019-05-07 | |
| 2018-12-31 | 102.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | 328.34K shares derived: sum of 2 quarters · filed 2019-02-26 | 621.73K shares derived: sum of 3 quarters · filed 2019-02-26 | 750.12K shares 10-K · filed 2019-02-26 | |
| 2018-09-30 | 225.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 518.78K shares derived: sum of 2 quarters · filed 2018-11-07 | 647.17K shares 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | 293.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 421.78K shares 10-Q · filed 2018-08-07 | |||
| 2018-03-31 | 128.39K shares 10-Q · filed 2018-05-10 | ||||
| 2017-09-30 | 53.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | 177.25K shares derived: sum of 2 quarters · filed 2017-11-02 | 237.49K shares 10-Q · filed 2017-11-02 | ||
| 2017-06-30 | 124.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 184.44K shares 10-Q · filed 2017-08-08 | |||
| 2017-03-31 | 60.25K shares 10-Q · filed 2017-05-09 | ||||
| 2016-09-30 | 5.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 23.41K shares derived: sum of 2 quarters · filed 2016-11-10 | 36.99K shares 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | 18.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 31.77K shares 10-Q · filed 2016-08-11 | |||
| 2016-03-31 | 13.58K shares 10-Q · filed 2016-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |